BANGALORE, India, Dec. 12, 2019 /PRNewswire/ — Avesthagen Limited, a leading systems biology life sciences company, announces the acceleration of its Avestagenome Project®. This research study focuses on the Indian and Parsi communities and the aim is to understand the linkage between genes, environmental factors, and disease, with an initial look into the role of smoking in developing lung, oral and oesophageal cancers.

Since 2008, the Avestagenome Project® has been collecting a biobank of Parsi blood samples and extensive patient data from over 4,500 members of this community with a target of 15,000 Parsis globally by 2021. The molecular basis of longevity and age-related disorders, prioritising cancers, cardiovascular disease, diabetes and neurological disorders will be investigated in this cohort specifically. The project will provide insights into disease prediction and accelerate identification and development of biomarkers, predictive diagnostic tests, new drugs, and therapies…..READ MORE

Leave a Reply

Your email address will not be published.

POSTED BY News | Dec, 12, 2019 |